Journal of Pharmaceutical Research and Drug Design is designed to compact with the diverse research areas related to pharmaceutics and drug design. Journal mainly focus on research contributions pertaining to drug design, drug discovery, natural products, formulation, drug specificity, optimizing dosage regimen, drug delivery systems and regulation, personalized medicine, testing the efficacy of drug molecule in vitro and in vivo, pharmacokinetics, pharmacogenomics, analytical sciences, nanotechnology, therapeutic aspects, quality control, optimization by medicinal chemistry, drug pharmacodynamics, evaluation of safety and toxicity of drug molecules, regulatory science as well as computational approaches.
The goal of this journal is to publish high-quality original research work and reviews in all related disciplines relevant to pharmaceutics and drug design under the same panel. We welcome academicians, researchers, scholars, clinicians, and scientists to submit their pioneer work resulting in underscore interdisciplinary and integrated research determination. The journal is outlined to cover all disciplines and challenges in science, technology, and engineering that promote the advances in newly improved drug molecules and their uses involving pharmaceutical aspects to the scientific community. Journal of Pharmaceutical Research and Drug Design encapsulates a wide range of topics in pharmaceutics and pharmaceutical sciences. The overall aim of the journal is to publish high-quality peer-reviewed scientific papers to the scientific global community. JPRDD is a bimonthly journal that encourages authors from all over the sphere to submit their manuscripts for publication and prop up the world to fill in their awareness by sharing most recent development. We accept original research articles, reviews, mini-reviews, short communication articles, editorials, perspectives and letters from authors beginning every corner of the globe for publication in our journal.
Every article submitted by authors are evaluated by editorial board members or a group of peer review experts in the field confirming that the published articles are of high quality and that the information they contain is accurate and reliable.
Open Access Publication and Creative Commons Licensing:
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share A like 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Ahead of Print policy:
Articles published online under the Ahead of Print models are considered published and can be cited and quoted using the DOI as the reference source. Acquaint has a policy that changes will not be made after publication of an article without following accepted procedures for making corrections to the scientific record.
Chemical processing of Pharmaceutical drugs
Dosage form design
Pharmaceutical Research and Analysis
Targeted drug delivery
Biotechnology and nano-technology
Chemical Biology Drug Design
Computer-assisted Drug Design
Drug Discovery Hit to Lead
Drug-drug & Drug-Chemical Interactions
Herbal Drug Development
In Silico Drug Design
Molecular Drug Design
Nano-materials in Drug Designing
Physiologically-Based Pharmacokinetic Modelling
Protein structure prediction and molecular simulation
Quantitative Structure Activity Relationships
Rational Drug Design
Retrometabolic Drug Design
Structure-Based Drug Design
Translational Drug Development